JFL Life Sciences Limited IPO

JFL Life Sciences Limited is listed in the SME segment with a price band of ₹61 to ₹61. The figures below are as reported by the exchanges and public sources.

JFL Life Sciences Limited IPO — key facts

• The JFL Life Sciences Limited IPO price band is ₹61 to ₹61 per share.
• As of 5 September 2026, the JFL Life Sciences Limited IPO subscription status is 8.93x overall.
• The issue is open from 25-AUG-2022 to 30-AUG-2022.
• JFL Life Sciences Limited listed on 08-SEP-2022.
• JFL Life Sciences Limited listed at ₹66.5. The listing gain was 9.0% against the upper end of the issue price band.

JFL Life Sciences Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹61 – ₹61

Issue size

₹17.25 Cr

Fresh issue

₹17.25 Cr

Opens

25-AUG-2022

Closes

30-AUG-2022

Listing

08-SEP-2022

Total subscription

8.93x

Retail

11.66x

NII

6.19x

Lead managers

GYR Capital (left lead)

Listing price

₹66.5

Listing day change

+9.0%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.